The research progress in the interaction between Candida albicans and cancers
Candida albicans is an opportunistic pathogenic fungus, which tends to infect the host with defective immune function including cancer patients. A growing number of studies have shown that C. albicans infection increases the host susceptibility to cancer such as oral, gastric, and colorectal cancer. Cancer and anti-cancer treatment may also affect the colonization of C. albicans. C. albicans may promote the development of cancer by damaging mucosal epithelium, inducing the production of carcinogens, triggering chronic inflammation including Th17 cell-mediated immune response. In this article, we aim to elaborate the interaction between C. albicans and cancers development and summarize the potential molecular mechanisms, so as to provide theoretical basis for prevention, diagnosis and treatment of cancers.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Oncology
3 publications, 10%
|
|
|
Frontiers in Cellular and Infection Microbiology
2 publications, 6.67%
|
|
|
Clinical and Translational Oncology
1 publication, 3.33%
|
|
|
Microorganisms
1 publication, 3.33%
|
|
|
RSC Medicinal Chemistry
1 publication, 3.33%
|
|
|
Cancers
1 publication, 3.33%
|
|
|
Microbiology spectrum
1 publication, 3.33%
|
|
|
Polymer Bulletin
1 publication, 3.33%
|
|
|
Frontiers in Microbiology
1 publication, 3.33%
|
|
|
Journal of Infection
1 publication, 3.33%
|
|
|
Critical Reviews in Microbiology
1 publication, 3.33%
|
|
|
Biochemical Pharmacology
1 publication, 3.33%
|
|
|
mBio
1 publication, 3.33%
|
|
|
World Journal of Gastrointestinal Oncology
1 publication, 3.33%
|
|
|
Materials Chemistry and Physics
1 publication, 3.33%
|
|
|
Medicina
1 publication, 3.33%
|
|
|
Endocrine and Metabolic Science
1 publication, 3.33%
|
|
|
Gene
1 publication, 3.33%
|
|
|
Cancer Pathogenesis and Therapy
1 publication, 3.33%
|
|
|
Nutrients
1 publication, 3.33%
|
|
|
Molecular Cancer
1 publication, 3.33%
|
|
|
International Journal of Molecular Sciences
1 publication, 3.33%
|
|
|
Nature Microbiology
1 publication, 3.33%
|
|
|
Expert Review of Anti-Infective Therapy
1 publication, 3.33%
|
|
|
Medical Oncology
1 publication, 3.33%
|
|
|
Interdisciplinary Perspectives on Infectious Diseases
1 publication, 3.33%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
5
6
|
|
|
Springer Nature
6 publications, 20%
|
|
|
Frontiers Media S.A.
6 publications, 20%
|
|
|
Elsevier
6 publications, 20%
|
|
|
MDPI
5 publications, 16.67%
|
|
|
American Society for Microbiology
2 publications, 6.67%
|
|
|
Taylor & Francis
2 publications, 6.67%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 3.33%
|
|
|
Baishideng Publishing Group
1 publication, 3.33%
|
|
|
Hindawi Limited
1 publication, 3.33%
|
|
|
1
2
3
4
5
6
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.